Released Aug 4, 2022, after the close
10-Q filed Aug 5, 2022, 36 days after period end · 0001636422-22-000041
Q2 2022 · 10-Q
Revenue$70.63M$70.63M +18.5% vs Q2 2021+3.7% vs Q1 2022
Net Income-$33.43M-$33.43M N/M vs Q2 2021N/M vs Q1 2022
EPS Diluted-$0.62-$0.62 N/M vs Q2 2021N/M vs Q1 2022
Operating Income-$33,192,000N/M
Operating Cash Flowderived-$9,576,000N/M
Free Cash Flowderived-$9,778,000N/M
Margins · derived
Operating margin-47.0%+7.2 pt vs Q2 2021
Net margin-47.3%+12.8 pt vs Q2 2021
What the release said
The release
Same quarter
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $70.63M | $59.63M | $43.26M | $36.80M |
| Net Income | -$33.43M | -$35.83M | -$27.18M | -$10.69M |
| EPS Diluted | -$0.62 | -$0.80 | -$0.71 | -$21.98 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR